✦ LIBER ✦

EGFR Inhibitors in Cancer Treatment || Clinical results with EGFR inhibitors in NSCLC and their use in the treatment of metastatic disease

✍ Scribed by Ciardiello, Fortunato

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EGFR mutations in squamous NSCLC – Preva

✍ Berzinec, P.; Hlinkova, K.; Copakova, L.; Konecny, M.; Zavodna, K.; Cerna, M.; C 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 81 KB

344 EGFR inhibitors in the treatment of

✍ G. Giaccone 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 171 KB

EGFR tyrosine kinase inhibitors for the

✍ Yang, Chih-Hsin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 147 KB

6119 Triple mutational testing for respo

✍ Spindler, K.; Pallisgaard, N.; Lindebjerg, J.A.N.; Jakobsen, A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

The use of first-generation tyrosine kin

✍ Riely, Gregory J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Expression levels of EGFR in malignant g

✍ D.A. Haas-Kogan; M.D. Prados; N. Jelluma; N.D. Arvold; K.R. Lamborn; A. Kapadia; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 70 KB